查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球脑图设备市场，到 2030 年的预测：按产品类型、最终用户和地区分類的全球分析
市场调查报告书
商品编码
1371982

全球脑图设备市场，到 2030 年的预测：按产品类型、最终用户和地区分類的全球分析

Brain Mapping Instruments Market Forecasts to 2030 - Global Analysis By Product Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球脑图设备市场规模将达25亿美元，预计2030年将达到42亿美元，预测期内年复合成长率为8.1%。

脑图谱是切除肿瘤时检测和保护关键大脑区域最准确的技术。对于肿瘤靠近大脑言语、运动或感觉部分的患者来说，这种手术可能是必要的。医生可以尽可能切除脑肿瘤，同时尽量减少对控制运动、语言和感觉的大脑重要区域的影响。

根据世界卫生组织（WHO）2021年9月的最新资讯，2021年全球约有5500万人患有失智症，每年报告的病例近1000万例。

神经系统疾病增加

目标人口中神经系统疾病的流行意味着脑图设备在医疗设备业的使用可能会更加迅速地扩大，为这些工具的市场创造了新的机会。此外，技术进步预计将导致全球几家领先公司推出更多新产品，预计将对市场成长产生积极影响。

高成本

购买和维护脑图设备（例如 MRI 扫描仪、脑电图系统和脑磁图机）的成本可能很高。这些设备的高成本可能是一个限制，特别是对于资金有限的医疗机构。设备成本可能会阻碍普及，特别是在资源有限的地区。

技术开发

随着脑部影像和图谱技术的不断发展，脑图谱设备市场潜力巨大。为了更准确地绘製大脑活动图，功能性磁振造影(fMRI)、脑电图 (EEG) 和脑磁图 (MEG) 等新影像技术可提供更高的空间和时间解析度。我是。此外，技术的发展导致绘製人脑图的设备变得更加复杂和精确。这些技术提供了更强大的资料收集和分析能力、更高品质的影像以及改进的与其他系统和设备的通讯。这些进步使科学家和研究人员能够更好地了解大脑如何运作、神经网路如何运作以及相关疾病如何运作。

无障碍问题

并非所有地方都能平等获得脑图设备，尤其是在农村和低收入国家。缺乏基础设施，包括医疗设施和合格的工人，可能会限制脑图设备的取得和使用。然而，有限的存取限制阻碍了这些技术的普遍普及，从而限制了市场的扩张。

COVID-19 的影响

COVID-19 是一场意想不到的全球公共卫生紧急事件，几乎影响着所有企业。例如，根据 2021 年 12 月发表在《阿兹海默症期刊》上的一篇论文，COVID-19 不仅影响呼吸系统，还会引起神经和神经精神疾病。报告称，该病毒会影响中枢神经系统（CNS），即使在 COVID-19 症状消退后也可能导致认知障碍。结果，COVID-19 感染者的神经症状恶化。于是就需要脑图设备，这对疫情期间的市场拓展产生了重大影响。

预计在预测期内医院部门将是最大的

由于住院患者数量的增加和主要市场参与企业推出的产品，医院部门在预测期内占据最大份额。此外，美国医院数量的增加正在刺激市场扩张。根据美国心臟协会（AHA）2021年1月发布的数据，2021年美国投资者拥有的（营利性）社区医院数量为1,228家，而州和地方地方政府医院的数量为951家。此外，大量医院产生对脑图设备的需求，预计将推动市场扩张。

预计脑电图 (EEG) 领域在预测期内年复合成长率最高

由于能够使用影像技术诊断癫痫和癫痫等脑部疾病，脑电图 (EEG) 领域预计在预测期内具有最高的年复合成长率。此外，脑电图是一种有助于识别大脑电活动变化的诊断方法。因此，检测各种大脑挑战的快速应用进程正在推动市场扩张。

占比最高的地区

由于美国神经系统疾病罹患率不断上升、新技术接受度较早以及医疗基础设施不断加强，北美目前在全球脑图设备市场占据主导地位。例如，据阿兹海默症协会称，2021年约有620万65岁以上的美国将患有阿兹海默失智症，预计到2050年这一数字将上升至1,270万。此外，高度发展的医疗保健系统和对研发的重视为该地区最尖端科技的实施提供了有利的环境。这些因素正在推动该地区的成长。

复合年复合成长率最高的地区

由于健康问题日益严重和最尖端科技的日益采用，预计亚太地区将在预测期内快速扩张。 NCBI 报告称，该地区神经系统疾病的患病正在增加，导致大脑结构和认知功能的影像研究增加。此外，平面回波成像 (EPI) 等新方法正在用于治疗脑部疾病患者。快速磁振造影技术（EPI）可以在很短的时间内取得磁振造影影像。因此，脑部疾病的流行和该地区最尖端科技的采用正在推动市场扩张。

免费客製化服务

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究来源
    • 主要研究来源
    • 二次研究来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球脑图谱设备市场：依产品类型

  • 磁振造影(MRI)
  • 近红外线光光谱 (NIRS)
  • 脑电图（EEG）
  • 正子断层扫描 (PET)
  • CT检查
  • 其他产品类型

第6章全球脑图谱设备市场：依最终用户分类

  • 门诊中心
  • 医院
  • 其他最终用户

第7章全球脑图谱设备市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第8章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第9章公司简介

  • Advanced Brain Monitoring, Inc
  • Artinis Medical Systems
  • Canon Medical Systems Corp
  • General Electric Company
  • Gowerlabs Ltd
  • Koninklijke Philips NV
  • Medtronic
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • NIRx Medical Technologies, LLC
  • Siemens Healthcare Private Limited
  • Soterix Medical Inc
Product Code: SMRC24038

According to Stratistics MRC, the Global Brain Mapping Instruments Market is accounted for $2.5 billion in 2023 and is expected to reach $4.2 billion by 2030 growing at a CAGR of 8.1% during the forecast period. The most accurate technique to detect and safeguard important brain regions while removing a tumor is through brain mapping. This operation may be necessary for patients whose tumors are close to the linguistic, motor, or sensory parts of the brain. Doctors have been able to remove as much of a brain tumor as feasible while limiting the effect on the vital regions of the brain that regulate movement, speech, and the senses.

According to the September 2021 update by the World Health Organization (WHO), about 55 million people worldwide were living with dementia in 2021, and nearly 10 million cases are reported every year.

Market Dynamics:

Driver:

Increase in neurological conditions

The prevalence of neurological disorders among the target population means that the use of brain mapping instruments in the medical device industry is likely to grow more rapidly, opening up new opportunities for the market for these tools. Additionally, the increased introduction of new products by several major players globally as a result of enhanced technology is anticipated to positively affect market growth.

Restraint:

High costs

The cost of purchasing and maintaining brain mapping equipment like MRI scanners, EEG systems, and MEG devices can be high. These instruments' high costs can be a constraint, especially for healthcare facilities with limited funds. The cost of the tools may prevent their widespread use, particularly in areas with limited resources.

Opportunity:

Technological development

The market for brain mapping instruments has a lot of potential due to the ongoing developments in brain imaging and mapping technology. In order to map brain activity more precisely, new imaging techniques, including functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and magnetoencephalography (MEG), offer greater spatial and temporal resolution. Additionally, technology development has produced more complex and precise instruments for mapping the human brain. These technologies provide better data collection and analysis capacities, higher-quality images, and improved communication with other systems and devices. These advancements offer scientists and researchers a better understanding of how the brain works, how neural networks work, and how related illnesses work.

Threat:

Accessibility issues

Not all locations have equal access to brain mapping instruments, particularly rural and low-income nations. The accessibility and availability of brain mapping tools may be constrained by a lack of infrastructure, including healthcare facilities and competent workers. However, as it prevents the general adoption of these technologies, this restricted accessibility limits market expansion.

COVID-19 Impact:

An unexpected global public health emergency, COVID-19, has had an impact on practically every business. For instance, COVID-19 not only affects the respiratory system but also causes neurological and neuropsychiatric diseases, according to an article published in the Journal of Alzheimer's Diseases in December 2021. According to this, the virus may have an impact on the central nervous system (CNS), which could lead to cognitive impairment even after COVID-19 symptoms have subsided. As a result, people with COVID-19 developed worse neurological conditions. As a result, there was a need for brain mapping instruments, which had a major effect on market expansion during the epidemic.

The hospitals segment is expected to be the largest during the forecast period

Due to a rise in hospital admissions and product launches by the major market participants, the hospital segment dominated the largest share over the forecast period. The expansion of the market is also being fueled by the rising number of hospitals in the United States. According to numbers from the American Heart Association (AHA) released in January 2021, there were 1,228 investor-owned (for-profit) community hospitals in the United States in 2021, compared to 951 state and local government community hospitals. Moreover, the demand for brain mapping instruments is generated by the enormous number of hospitals, which is anticipated to fuel market expansion.

The Electroencephalography (EEG) segment is expected to have the highest CAGR during the forecast period

Due to its capabilities of using imaging techniques to diagnose brain illnesses, including epilepsy and seizures, the electroencephalography (EEG) segment is anticipated to have the highest CAGR throughout the projection period. Moreover, it is a method of diagnosis that aids in identifying alterations in the electrical activity of the brain. Therefore, it is promoting market expansion due to its quicker application process for detecting various brain challenges.

Region with largest share:

Due to the rising incidence of neurological illnesses, early acceptance of new technologies, and enhanced healthcare infrastructure in the US, North America currently holds a dominant position in the global market for brain mapping instruments. For instance, according to the Alzheimer's Association, in 2021, there were around 6.2 million Americans 65 and older who had Alzheimer's dementia, and that number is predicted to rise to 12.7 million by the year 2050. Moreover, the highly developed healthcare system and concentration on research and development provide a climate that is favorable to the adoption of cutting-edge technologies in the region. These elements are boosting the region's growth.

Region with highest CAGR:

Owing to growing health concerns and increased adoption of cutting-edge technologies, Asia-Pacific is anticipated to expand at a rapid pace over the course of the projected period. The NCBI reports that the rising prevalence of neurological illnesses in the area has led to an increase in neuroimaging investigations of brain structure and cognitive functioning. The treatment of individuals with brain illnesses has also adapted new methods, such as echo-planar imaging (EPI). The rapid MRI technique known as EPI can acquire MR images in a very short amount of time. As a result, the prevalence of brain illnesses and the adoption of cutting-edge technologies in the region have fueled market expansion.

Key players in the market:

Some of the key players in Brain Mapping Instruments market include: Advanced Brain Monitoring, Inc, Artinis Medical Systems, Canon Medical Systems Corp, General Electric Company, Gowerlabs Ltd, Koninklijke Philips N.V., Medtronic, Natus Medical Incorporated, Nihon Kohden Corporation, NIRx Medical Technologies, LLC, Siemens Healthcare Private Limited and Soterix Medical Inc.

Key Developments:

In September 2022, Scientists at the Allen Institute established the Brain Genome Project, a new global partnership to map approximately 200 billion cells in the human brain by type and function.

In March 2022, Kernel, a neurotechnology company, developed a wearable headset device, Kernel Flow, for brain measurement, which is based on time-domain functional near-infrared spectroscopy (TD-fNIRS). The device enables accurate, high-resolution measurement of the brain, and it functions by emitting picosecond pulses of light into tissue and measuring the arrival times of single photons.

Product Types Covered:

  • Magnetic Resonance Imaging (MRI)
  • Near-Infrared Spectroscopy (NIRS)
  • Electroencephalography (EEG)
  • Positron Emission Tomography (PET)
  • Computed Tomography
  • Other Product Types

End Users Covered:

  • Ambulatory Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Brain Mapping Instruments Market, By Product Type

  • 5.1 Introduction
  • 5.2 Magnetic Resonance Imaging (MRI)
  • 5.3 Near-Infrared Spectroscopy (NIRS)
  • 5.4 Electroencephalography (EEG)
  • 5.5 Positron Emission Tomography (PET)
  • 5.6 Computed Tomography
  • 5.7 Other Product Types

6 Global Brain Mapping Instruments Market, By End User

  • 6.1 Introduction
  • 6.2 Ambulatory Centers
  • 6.3 Hospitals
  • 6.8 Other End Users

7 Global Brain Mapping Instruments Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Advanced Brain Monitoring, Inc
  • 9.2 Artinis Medical Systems
  • 9.3 Canon Medical Systems Corp
  • 9.4 General Electric Company
  • 9.5 Gowerlabs Ltd
  • 9.6 Koninklijke Philips N.V.
  • 9.7 Medtronic
  • 9.8 Natus Medical Incorporated
  • 9.9 Nihon Kohden Corporation
  • 9.10 NIRx Medical Technologies, LLC
  • 9.11 Siemens Healthcare Private Limited
  • 9.12 Soterix Medical Inc

List of Tables

  • Table 1 Global Brain Mapping Instruments Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 4 Global Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 5 Global Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 6 Global Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 7 Global Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 8 Global Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 9 Global Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 10 Global Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 11 Global Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 12 Global Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 13 North America Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 14 North America Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 15 North America Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 16 North America Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 17 North America Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 18 North America Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 19 North America Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 20 North America Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 21 North America Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 North America Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 23 North America Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 24 North America Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 Europe Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 Europe Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 27 Europe Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 28 Europe Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 29 Europe Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 30 Europe Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 31 Europe Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 32 Europe Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 33 Europe Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 34 Europe Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 35 Europe Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 36 Europe Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 37 Asia Pacific Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Asia Pacific Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 39 Asia Pacific Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 40 Asia Pacific Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 41 Asia Pacific Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 42 Asia Pacific Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 43 Asia Pacific Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 44 Asia Pacific Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 45 Asia Pacific Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 46 Asia Pacific Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 47 Asia Pacific Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 48 Asia Pacific Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 South America Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 South America Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 51 South America Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 52 South America Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 53 South America Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 54 South America Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 55 South America Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 56 South America Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 57 South America Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 58 South America Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 59 South America Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 60 South America Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 Middle East & Africa Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Middle East & Africa Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 63 Middle East & Africa Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 64 Middle East & Africa Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 65 Middle East & Africa Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 66 Middle East & Africa Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 67 Middle East & Africa Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 68 Middle East & Africa Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 69 Middle East & Africa Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 70 Middle East & Africa Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 71 Middle East & Africa Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 72 Middle East & Africa Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)